114 participants
Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Injection in Healthy Participants
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-12-12
- Start Date:
- 2017-08-01
- Completion:
- 2017-12-15
Conditions
- Healthy Participants
Interventions
- DRUG
No Results Yet